KURN.SW Stock — Price, Charts & Analysis

Kuros Biosciences AG (KURN.SW) has a trailing P/E of 113.26x and a forward P/E of 41.75x. This places KURN.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

KURN.SW trades with 113.26x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether KURN.SW looks overvalued or undervalued.

KURN.SW's P/E of 113.26x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

KURN.SW's trailing EPS is CHF 0.19 and forward EPS is CHF 0.52.

EPS, or earnings per share, shows how much profit Kuros Biosciences AG generated for each share. KURN.SW's trailing EPS is CHF 0.19, and investors usually prefer EPS that is positive and growing over time.

Kuros Biosciences AG has a market cap of CHF 853.74M, making KURN.SW a small-cap stock based on the current market value shown on Worldtickers.

KURN.SW's latest stock price on Worldtickers is CHF 21.52. The latest move is -CHF 0.94 or -4.19%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

KURN.SW's quote includes a latest price of CHF 21.52. The market open is CHF 22.18. Previous close is CHF 22.46. The intraday range is CHF 21.52 to CHF 22.18.

KURN.SW is down in the latest quote, with a move of -CHF 0.94 or -4.19%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

KURN.SW generated CHF 174.93M in trailing revenue. Revenue growth is 45.50%, which helps show whether demand is expanding or slowing.

KURN.SW's revenue growth is 45.50%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, KURN.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 8.90M.

Gross margin is 86.37%. Margins show how efficiently Kuros Biosciences AG turns revenue into profit.

KURN.SW's book value per share is CHF 1.75.

Institutions hold 22.00% of KURN.SW shares. Insiders hold 28.74% of shares. Ownership mix helps investors understand how much of Kuros Biosciences AG is held by professional investors and company insiders.

KURN.SW has 39.67M shares outstanding. Float shares are 29.66M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for KURN.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for KURN.SW is CHF 0.52. Revenue growth is 45.50%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

KURN.SW's trailing EPS is CHF 0.19. Forward EPS is CHF 0.52. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

KURN.SW is in the Healthcare sector. Its earnings multiple is 113.26x. Its latest displayed growth metric is 45.50%. Compare these figures with sector peers before deciding whether Kuros Biosciences AG is stronger or weaker than average.

KURN.SW trades at CHF 21.52. The stock trades at 113.26x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Kuros Biosciences AG's fundamentals.

KURN.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.76, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

KURN.SW should be compared with companies in Medical Devices. Its earnings multiple is 113.26x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Kuros Biosciences AG (KURN.SW) operates in Healthcare, specifically Medical Devices. Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasi

KURN.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

KURN.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Kuros Biosciences AG's official website listed on Worldtickers is kurosbio.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Kuros Biosciences AG employs about 178 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Kuros Biosciences AG is headquartered in Schlieren, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

KURN.SW is in the Healthcare sector and the Medical Devices industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

KURN.SW has traded between CHF 17.69 and CHF 34.20 over the past 52 weeks. At CHF 21.52, it is 37.08% below the high and 21.65% above the low. The 52-week range helps gauge long-term price momentum.

KURN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is CHF 20.80 and its 200-day moving average is CHF 24.15.

KURN.SW's RSI is 47.38. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

KURN.SW's latest RSI reading is 47.38, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for KURN.SW is near CHF 19.40. Key resistance is near CHF 24.50. Breaks above resistance or below support can change the short-term technical setup.

KURN.SW's nearest reported support level is CHF 19.40. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

KURN.SW's nearest reported resistance level is CHF 24.50. A breakout above resistance can improve momentum, especially when volume confirms the move.

KURN.SW trades about 185.99K shares daily on average. The latest displayed volume is 322.36K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

KURN.SW's MACD is -0.19, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

KURN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 47.38 (neutral). MACD is bearish. Nearest support is around CHF 19.40. Resistance is around CHF 24.50. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 22.44 (-4.11% from price). MA50 is CHF 20.80 (3.44% from price). MA200 is CHF 24.15 (-10.88% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. KURN.SW's MA20 is CHF 22.44. MA50 is CHF 20.80. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

KURN.SW's pivot is near CHF 22.94. Support is near CHF 19.40. Resistance is near CHF 24.50. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for KURN.SW is near CHF 19.81. The next upper resistance zone is near CHF 23.61. These levels help define risk and possible follow-through zones after a breakout or breakdown.

KURN.SW's Bollinger range is roughly CHF 20.64 to CHF 24.24. Band width is near 16.06%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

KURN.SW's ATR-based typical daily range is about 5.23%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 322.36K shares. Average volume is about 185.99K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

KURN.SW's all-time high shown on Worldtickers is CHF 14,458.16. Its all-time low is CHF 1.11. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

KURN.SW has a beta of 0.76, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.